2007•Unpublished venueRequires access

Pharmacogenetics and Personalized Medicine

Julie A. Johnson, Issam Zineh

Abstract

This chapter contains section titled: Introduction Pharmacogenetics of Dyslipidemia Relevance of Pharmacogenetics to Treatment of Dyslipidemias Pharmacogenetics of Hypertension Relevance of Pharmacogenetics to the Treatment of Hypertension Pharmacogenetics of Heart Failure Pharmacogentics of Other Heart Failure Drugs Relevance of Pharmacogenetics to Management of Heart Failure Pharmacogenetics of Thrombosis Antiplatelet Pharmacogenetics Anticoagulants Antithrombin Pharmacogenetics Pharmacogenetics of Arrhythmia and Proarrhythmia Future Directions in Cardiovascular Pharmacogenetics

About this research paper

What this paper is about

Why it matters

OpenAlex reports 2 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Key concepts: Pharmacogenetics, Medicine, Personalized medicine, Dyslipidemia, Pharmacology, Bioinformatics, Internal medicine, Genotype